Literature DB >> 16624469

Bovine brain phosphatidylserine attenuates scopolamine induced amnesia in mice.

Flavia T Claro1, Camilla L Patti, Vanessa C Abílio, Roberto Frussa-Filho, Regina H Silva.   

Abstract

This study verifies the effects of bovine brain phosphatidylserine (PS) on passive avoidance (PA) and contextual fear conditioning (CFC) tests in scopolamine-treated mice. Mice received daily i.p. 50 mg/kg PS or 0.2 M Tris pH 7.4 (TRIS) for 5 days. On day 6, mice received saline (TRIS-SAL and PS-SAL) or 1 mg/kg SCO (TRIS-SCO and PS-SCO) i.p. After 20 min, the animals were submitted to PA (experiment 1) or CFC (experiment 2) training sessions, and tests were performed 24 h later. Latency in entering the dark chamber of the PA apparatus presented by TRIS-SCO (but not PS-SCO) group in the test was significantly higher than those presented by controls. Except for TRIS-SCO, all the groups presented higher latencies in the test compared to the training session. In experiment 2, the TRIS-SCO (but not PS-SCO) group presented significantly lower freezing duration than that presented by the TRIS-SAL group in the test. Animals treated with PS alone presented higher freezing duration than that presented by the TRIS-SAL group. The results demonstrate that PS attenuates SCO-induced amnesia in both PA and CFC tests. In addition, PS per se improves retention in the CFC test.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16624469     DOI: 10.1016/j.pnpbp.2006.01.013

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  3 in total

1.  Targeted metabolomics analysis of serum amino acid profiles in patients with Moyamoya disease.

Authors:  Xi Liu; Feng Jin; Pei Jiang; Changmeng Cui; Changshui Wang; Shiyuan Zhao; Shasha Han
Journal:  Amino Acids       Date:  2021-11-20       Impact factor: 3.520

2.  Glycerophospholipid Supplementation as a Potential Intervention for Supporting Cerebral Structure in Older Adults.

Authors:  Jeffery M Reddan; David J White; Helen Macpherson; Andrew Scholey; Andrew Pipingas
Journal:  Front Aging Neurosci       Date:  2018-03-07       Impact factor: 5.750

3.  A randomized controlled trial investigating the neurocognitive effects of Lacprodan® PL-20, a phospholipid-rich milk protein concentrate, in elderly participants with age-associated memory impairment: the Phospholipid Intervention for Cognitive Ageing Reversal (PLICAR): study protocol for a randomized controlled trial.

Authors:  Andrew B Scholey; David A Camfield; Matthew E Hughes; Will Woods; Con K K Stough; David J White; Shakuntla V Gondalia; Pernille D Frederiksen
Journal:  Trials       Date:  2013-11-26       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.